Grifols Shares Outstanding 2012-2018 | GRFS

Current and historical number of shares outstanding for Grifols (GRFS) from 2012 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Grifols Annual Shares Outstanding
(Millions of US $)
2017 $684
2016 $683
2015 $686
2014 $687
2013 $684
2012 $685
2011 $556
Grifols Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $675
Q1 2018 $0
Q2 2017 $685
Q1 2017 $670
Q4 2016 $683
Q3 2016 $675
Q2 2016 $696
Q1 2016 $696
Q4 2015 $0
Q3 2015 $683
Q2 2015 $682
Q1 2015 $676
Q4 2014 $691
Q3 2014 $692
Q2 2014 $692
Q1 2014 $691
Q4 2013 $714
Q3 2013 $674
Q2 2013 $673
Q1 2013 $663
Q4 2012 $791
Q3 2012 $670
Q2 2012 $693
Q1 2012 $675
Q4 2011 $912
Q3 2011 $572
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.643B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.165B 10.84
Zoetis (ZTS) United States $43.774B 31.77
Jazz Pharmaceuticals (JAZZ) Ireland $10.510B 15.47
Neurocrine Biosciences (NBIX) United States $10.313B 0.00
Nektar Therapeutics (NKTR) United States $10.110B 11.82
Sage Therapeutics (SAGE) United States $6.862B 0.00
Ionis Pharmaceuticals (IONS) United States $6.816B 0.00
United Therapeutics (UTHR) United States $5.429B 6.97
Catalent (CTLT) United States $5.389B 25.10
FibroGen (FGEN) United States $5.081B 0.00
Loxo Oncology (LOXO) United States $4.791B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.112B 15.92
Endo (ENDP) Ireland $3.596B 5.16
Madrigal Pharmaceuticals (MDGL) United States $3.592B 0.00
USANA Health Sciences (USNA) United States $3.129B 27.56
Heron Therapeutics (HRTX) United States $2.993B 0.00
Aerie Pharmaceuticals (AERI) United States $2.876B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.847B 0.00
Tilray (TLRY) United States $2.671B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.382B 0.00
Xencor (XNCR) United States $2.251B 0.00
PTC Therapeutics (PTCT) United States $2.029B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.964B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.705B 20.85
Zogenix (ZGNX) United States $1.671B 0.00
Portola Pharmaceuticals (PTLA) United States $1.663B 0.00
Impax Laboratories (AMRX) United States $1.620B 34.81
TESARO (TSRO) United States $1.497B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.479B 0.00
Corcept Therapeutics (CORT) United States $1.451B 22.32
ImmunoGen (IMGN) United States $1.320B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.298B 0.00
TherapeuticsMD (TXMD) United States $1.259B 0.00
Esperion Therapeutics (ESPR) United States $1.232B 0.00
Endocyte (ECYT) United States $1.154B 0.00
Karyopharm Therapeutics (KPTI) United States $1.087B 0.00
Tricida (TCDA) United States $0.988B 0.00
Radius Health (RDUS) United States $0.949B 0.00
Flexion Therapeutics (FLXN) United States $0.807B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.753B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.690B 0.00
CASI Pharmaceuticals (CASI) United States $0.658B 0.00
ArQule (ARQL) United States $0.650B 0.00
GlycoMimetics (GLYC) United States $0.634B 0.00
Siga Technologies (SIGA) United States $0.625B 0.00
Dova Pharmaceuticals (DOVA) United States $0.613B 0.00
ChemoCentryx (CCXI) United States $0.561B 33.56
OptiNose (OPTN) United States $0.555B 0.00
Majesco Entertainment (COOL) United States $0.551B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.539B 0.00
Collegium Pharmaceutical (COLL) United States $0.538B 0.00
Translate Bio (TBIO) United States $0.530B 0.00
Xeris Pharmaceuticals (XERS) United States $0.505B 0.00
Odonate Therapeutics (ODT) United States $0.504B 0.00
Lannett Co Inc (LCI) United States $0.504B 4.63
Aclaris Therapeutics (ACRS) United States $0.489B 0.00
Forty Seven (FTSV) United States $0.464B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.460B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.449B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.434B 0.00
Akebia Therapeutics (AKBA) United States $0.433B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.415B 0.00
Aquestive Therapeutics (AQST) United States $0.403B 0.00
Dermira (DERM) United States $0.403B 0.00
Concert Pharmaceuticals (CNCE) United States $0.383B 0.00
ElectroCore (ECOR) United States $0.374B 0.00
Mast Therapeutics (SVRA) United States $0.368B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 24.86
Zafgen (ZFGN) United States $0.348B 0.00
Neon Therapeutics (NTGN) United States $0.345B 0.00
Minerva Neurosciences (NERV) United States $0.330B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.294B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.270B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.269B 0.00
Opexa Therapeutics (ACER) United States $0.262B 0.00
Achaogen (AKAO) United States $0.252B 0.00
Melinta Therapeutics (MLNT) United States $0.252B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.244B 0.00
Ardelyx (ARDX) United States $0.244B 0.00
Jounce Therapeutics (JNCE) United States $0.243B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.239B 0.00
Aratana Therapeutics (PETX) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.233B 0.00
Tyme Technologies (TYME) United States $0.228B 0.00
IMV INC (IMV) Canada $0.226B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.222B 0.00
DURECT (DRRX) United States $0.211B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.198B 0.00
Adherex Technologies (FENC) United States $0.186B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.179B 0.00
MediWound (MDWD) Israel $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.163B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.161B 0.00
Neos Therapeutics (NEOS) United States $0.160B 0.00
Cardiome Pharma (CORV) Canada $0.159B 0.00
ContraFect (CFRX) United States $0.157B 0.00
Aldeyra Therapeutics (ALDX) United States $0.151B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Immune Design (IMDZ) United States $0.149B 0.00
ProNAi Therapeutics (SRRA) Canada $0.147B 0.00
Forward Pharma (FWP) Denmark $0.141B 0.00
KalVista Pharmaceuticals (KALV) United States $0.138B 0.00
MEI Pharma (MEIP) United States $0.137B 0.00
Molecular Templates (MTEM) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.129B 0.00
SteadyMed (STDY) Israel $0.127B 0.00
Recro Pharma (REPH) United States $0.118B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Rafael Holdings (RFL) United States $0.115B 0.00
Infinity Pharmaceuticals (INFI) United States $0.113B 0.00
CTI BioPharma (CTIC) United States $0.111B 0.00
Affimed (AFMD) Germany $0.094B 0.00
Otonomy (OTIC) United States $0.093B 0.00
BioLineRx (BLRX) Israel $0.093B 0.00
Nivalis Therapeutics (ALPN) United States $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.078B 0.00
Natural Alternatives (NAII) United States $0.074B 9.56
KemPharm (KMPH) United States $0.071B 0.00
Trillium Therapeutics (TRIL) Canada $0.070B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.069B 0.00
Novan (NOVN) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Genocea Biosciences (GNCA) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.049B 0.00
Mannatechorporated (MTEX) United States $0.049B 25.57
Tokai Pharmaceuticals (NVUS) United States $0.048B 0.00
Capnia (SLNO) United States $0.048B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.044B 36.95
Avenue Therapeutics (ATXI) United States $0.040B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.035B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.84
Biomerica (BMRA) United States $0.032B 0.00
Lipocine (LPCN) United States $0.031B 0.00
IsoRay (ISR) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Xenetic Biosciences (XBIO) United States $0.029B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
HANCOCK JAFFE (HJLI) United States $0.026B 0.00
Shineco (TYHT) China $0.024B 2.07
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Aradigm (ARDM) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Midatech Pharma (MTP) United Kingdom $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Egalet (EGLT) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Skyline Medical (AIPT) United States $0.016B 0.00
Pain Therapeutics (PTIE) United States $0.014B 0.00
PharmAthene (ALT) United States $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
India Globalization Capital (IGC) United States $0.012B 0.00
Intellipharmaceutics (IPCI) Canada $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.006B 0.00
Apricus Biosciences (APRI) United States $0.006B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.84
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00